This inventor holds 11 USPTO granted patents. Top assignees: Elan Pharmaceuticals, Inc., Pharmacia & Upjohn Company, Pharmacia & Upjohn. Active years: 2005-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hickory Corners, MI (US) (2005 - 2008)
- Nobelsville, IN (US) (2007 - 2008)
- Carmel, IN (US) (2007 - 2010)
Company Filing History:
8 out of 202 
7 out of 523 
1 out of 117 Years Active: 2005-2010
Title: **Shon R Pulley: Innovator in Alzheimer's Disease Research**
Introduction
Shon R Pulley, based in Hickory Corners, Michigan, is a prolific inventor with a notable portfolio of 11 patents. His work primarily focuses on the development of compounds aimed at treating Alzheimer's disease, showcasing his commitment to tackling significant health challenges through innovative solutions.
Latest Patents
Among his latest contributions, Pulley has developed compounds including Acetyl 2-hydroxy-1, 3-diaminoalkanes, which serve as inhibitors of the beta-secretase enzyme. These compounds hold promise in the treatment of Alzheimer's disease, particularly in reducing the deposition of the A beta peptide, a key factor in the progression of the disease. Additionally, he has patented macrocycles designed for similar purposes, emphasizing their utility in pharmaceutical compositions and treatment methods to mitigate A beta peptide formation.
Career Highlights
Shon R Pulley has made significant strides in his career, working for leading companies in the pharmaceutical industry. He has held positions at Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company, where he contributed to various projects aimed at innovation in medicine. His extensive experience in these reputable organizations has equipped him with the skills necessary to advance his research.
Collaborations
Throughout his career, Pulley has collaborated with esteemed colleagues, including Ruth Elizabeth TenBrink and Varghese John. These partnerships have undoubtedly enriched his research and led to noteworthy advancements in therapies targeting Alzheimer's disease.
Conclusion
Shon R Pulley's innovative spirit and dedication to improving medical treatments make him a notable figure in his field. His work on compounds for Alzheimer's disease reflects not only his expertise but also his desire to make a meaningful impact on public health through targeted innovations. With multiple patents to his name, Pulley continues to contribute to the evolving landscape of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile